+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Induced Pluripotent Stem Cells Production"

Induced Pluripotent Stem Cells Production Market 2024-2028 - Product Thumbnail Image

Induced Pluripotent Stem Cells Production Market 2024-2028

  • Report
  • May 2024
  • 169 Pages
  • Global
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Induced Pluripotent Stem Cells (iPSCs) are a type of stem cell that can be generated from adult cells, such as skin or blood cells. These cells have the potential to differentiate into any type of cell in the body, making them a valuable tool for drug discovery and development. In the pharmaceutical industry, iPSCs are used to create disease models, test drug efficacy, and develop personalized treatments. iPSCs are also used in regenerative medicine, where they can be used to replace damaged or diseased cells. This has the potential to revolutionize the treatment of many diseases, including cancer, diabetes, and neurological disorders. The iPSCs production market is growing rapidly, driven by increasing demand for personalized medicine and regenerative therapies. Companies in this market include Cellular Dynamics International, Takara Bio, and ReproCELL. Show Less Read more